Santhera Pharmaceuticals Holding Ltd. header image

Santhera Pharmaceuticals Holding Ltd.

SANN

Equity

ISIN CH1276028821 / Valor 127602882

SIX Swiss Exchange (2025-03-14)
CHF 15.00+0.27%

Santhera Pharmaceuticals Holding Ltd.
UMushroom community rating:

star star star star star
0.00 0 votes No rating yet
NegativeNeutralPositive

About company

Santhera Pharmaceuticals Holding Ltd. is a specialty pharmaceutical company based in Switzerland that focuses on the development and commercialization of innovative medicines for patients with rare diseases. The company is dedicated to addressing the unmet medical needs of individuals living with these conditions through the advancement of specialized treatments.

Summarized from source with an LLMView SourceSector: Technology

Latest Results (20.08.2024):

Revenue Growth

Santhera Pharmaceuticals Holding Ltd. reported a revenue of CHF 103.4 million for the year ended December 31, 2023. This significant revenue was primarily driven by the licensing deal with Catalyst Pharmaceuticals for AGAMREE in North America.

Net Income

For the same period, Santhera Pharmaceuticals Holding Ltd. achieved a net income of CHF 54.8 million. This positive financial outcome reflects the successful execution of strategic initiatives, including the Catalyst licensing agreement.

Cash Reserves

As of the end of 2023, Santhera Pharmaceuticals Holding Ltd. had CHF 30.4 million in cash reserves. These reserves, along with anticipated revenue from product sales, are expected to support the company's operations into 2025.

Debt Obligations

Santhera Pharmaceuticals Holding Ltd. acknowledged the need for additional funding to meet its debt obligations, including maturing convertible bonds. The company aims to achieve cash breakeven by the first half of 2026 through further market launches and strategic financial planning.

Product Launches

Santhera Pharmaceuticals Holding Ltd. successfully launched AGAMREE in Germany in January 2024, marking its first global market entry. The company plans to expand AGAMREE's availability to additional key geographies in Europe, including France, the UK, Italy, Spain, Benelux, and Switzerland.

Summarized from source with an LLMView Source

Key figures

56.6%1Y
10.1%3Y
-77.9%5Y

Performance

51.8%1Y
74.0%3Y
73.0%5Y

Volatility

Market cap

176 M

Market cap (USD)

Daily traded volume (Shares)

22,806

Daily traded volume (Shares)

1 day high/low

12.7 / 11.56

1 day high/low (USD)

52 weeks high/low

0.00 / 0.00

52 weeks high/low (USD)

Dividend ex-date

01 January, 2022

Dividend ex-date

Dividend

0.00

Dividend (USD)

Dividend yield (p.a.)

0.00%

Dividend yield (p.a.)

0.002022
0.002023
0.002024

Est dividend (USD)

0.00%2022
0.00%2023
0.00%2024

Est dividend yield

P/E ratio

10.00

P/E ratio

00.002022
00.002023
00.002024

Est P/E ratio

EPS

0.00

EPS (USD)

0.002022
0.002023
0.002024

Est EPS (USD)

Ratings & reviews

star star star star star

0.00

0 votes
Performance:
starstarstarstarstar
0.00
Innovation:
starstarstarstarstar
0.00
Society:
starstarstarstarstar
0.00
Nature:
starstarstarstarstar
0.00

EQUITIES OF THE SAME SECTOR

Super Micro Computer Inc
Super Micro Computer Inc Super Micro Computer Inc Valor: 138624448
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
7.91%USD 42.17
LEGRAND SA
LEGRAND SA LEGRAND SA Valor: 2501522
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
2.13%EUR 105.60
Worldline SA
Worldline SA Worldline SA Valor: 24715654
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.17%EUR 6.97
Rexel SA
Rexel SA Rexel SA Valor: 3015581
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
2.65%EUR 25.17
Ascendis Pharma
Ascendis Pharma Ascendis Pharma Valor: 26912602
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.44%USD 152.98
OVH GROUPE
OVH GROUPE OVH GROUPE Valor: 114137816
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
2.44%EUR 7.98
Vetoquinol SA
Vetoquinol SA Vetoquinol SA Valor: 1393361
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.56%EUR 71.60
Neurones
Neurones Neurones Valor: 837153
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
2.29%EUR 49.15
SOLUTIONS 30 SE
SOLUTIONS 30 SE SOLUTIONS 30 SE Valor: 44600804
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
1.68%EUR 1.69
Novanta Inc
Novanta Inc Novanta Inc Valor: 32582414
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
1.19%USD 136.07